←Back to Expert Scholars
Translational Medicine / 转化医学AML Novel Targets, Leukemia Trials
Jorge Cortes
MD
🏢Augusta University Georgia Cancer Center🌐USA
Director, Georgia Cancer Center
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jorge Cortes directs the Georgia Cancer Center and is a leader in leukemia drug development. He led trials that established glasdegib and other novel agents in AML. His career has contributed to multiple leukemia approvals and standards.
Share:
🧪Research Fields 研究领域
AML trials
CML
glasdegib
novel AML agents
leukemia drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jorge Cortes 的研究动态
Follow Jorge Cortes's research updates
留下邮箱，当我们发布与 Jorge Cortes（Augusta University Georgia Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment